A new study reported on October 6 suggests that even brief e-cigarette exposure may injure the deepest regions of the lung and leave the body less prepared to fight viral infection. Researchers at National Jewish Health found that just five days of vapor exposure triggered damage in distal lung tissue, with some effects still visible 10 days later.
Damage appeared quickly in delicate lung tissue
The team studied human lung epithelial and endothelial cells, along with precision-cut human lung tissue from the distal lung, the region where oxygen passes into the bloodstream. In preclinical models, exposure to e-cigarette vapor damaged the protective barrier, caused cellular stress, slowed cell growth and repair, and increased cell death within 24 hours.
According to the report, the injury also interfered with the cells’ internal process for clearing damaged components. The researchers said these changes were not limited to the exposure period itself, because signs of stress persisted well after vaping stopped.
Immune changes could help explain infection risk
The study also found that the immune impact extended beyond structural injury. The team observed lasting changes in barrier function, tissue remodeling, and Th1 immunity, a branch of the immune system that is important in fighting viral infections. Prior vaping exposure also increased SARS-CoV-2 viral burden and suppressed several antiviral genes after infection.
Senior author Irina Petrache said the findings suggest that even short-term vaping can start injury in the deepest and most delicate parts of the lung, and that some effects continue after exposure ends. The authors said the data may help explain why vaping has been associated with lung injury and greater susceptibility to respiratory infections.
Why the findings matter
The research was published in JCI Insight and, while it was conducted in preclinical models, the authors said the results warrant confirmation in people. They also noted that repeated exposure could potentially contribute to chronic lung disease by sustaining cellular injury and disrupting normal repair.
For clinicians and public health specialists, the findings add another warning sign to the growing evidence that vaping is not biologically benign, especially when it comes to lung defense and viral immunity.
More details are available from News-Medical and the linked journal reference in the report.
Photo source: AI-generated or edited image
